MXPA04000450A - Preparacion medica para inyeccion parenteral. - Google Patents

Preparacion medica para inyeccion parenteral.

Info

Publication number
MXPA04000450A
MXPA04000450A MXPA04000450A MXPA04000450A MXPA04000450A MX PA04000450 A MXPA04000450 A MX PA04000450A MX PA04000450 A MXPA04000450 A MX PA04000450A MX PA04000450 A MXPA04000450 A MX PA04000450A MX PA04000450 A MXPA04000450 A MX PA04000450A
Authority
MX
Mexico
Prior art keywords
medical preparation
parenteral injection
medical
preparation
trouble
Prior art date
Application number
MXPA04000450A
Other languages
English (en)
Inventor
Miyako Yasuhiro
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of MXPA04000450A publication Critical patent/MXPA04000450A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se relaciona con un procedimiento para suprimir el espumado que pueda presentarse en el momento de la preparacion de una solucion o una suspension. Particularmente, la presente invencion se relaciona con sustancias farmaceuticas, alimentos y similares en donde se suprime el espumado en el momento de la preparacion de una solucion o una suspension, lo cual puede provocar alguna desventaja.
MXPA04000450A 2001-07-17 2002-07-16 Preparacion medica para inyeccion parenteral. MXPA04000450A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001216617 2001-07-17
PCT/JP2002/007190 WO2003007967A1 (fr) 2001-07-17 2002-07-16 Preparation medicale pour injection parenterale

Publications (1)

Publication Number Publication Date
MXPA04000450A true MXPA04000450A (es) 2004-03-18

Family

ID=19051074

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000450A MXPA04000450A (es) 2001-07-17 2002-07-16 Preparacion medica para inyeccion parenteral.

Country Status (10)

Country Link
US (1) US7645793B2 (es)
EP (1) EP1407775A4 (es)
JP (1) JP4636795B2 (es)
KR (1) KR100896375B1 (es)
CN (1) CN1286462C (es)
BR (1) BR0211269A (es)
CA (1) CA2453996C (es)
MX (1) MXPA04000450A (es)
TW (1) TWI232102B (es)
WO (1) WO2003007967A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004108163A1 (ja) * 2003-06-04 2004-12-16 Shionogi & Co., Ltd. 低帯電性粉末の製造方法
TWI335335B (en) 2004-03-24 2011-01-01 Shionogi & Co A novel crystal of a triterpene derivative

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2836541A (en) * 1953-12-04 1958-05-27 Sterling Drug Inc Mannitol stabilized morphinepapaverine composition
US4604377A (en) * 1984-03-28 1986-08-05 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
JPS61165322A (ja) 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
US4889862A (en) 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
US4743450A (en) 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
JPS63261426A (ja) 1987-04-17 1988-10-28 Fujitsu Ltd 用語階層構成表示方式
US5089503A (en) 1987-06-03 1992-02-18 Hoffmann-La Roche Inc. Temperature stable 5-fluorouracil compositions
JPH03193735A (ja) * 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JP3193735B2 (ja) 1991-07-24 2001-07-30 株式会社リコー カラー画像形成装置の搬送装置
DK0628569T3 (da) 1993-06-11 1996-09-30 Shionogi & Co Triterpenderivater og endothelinreceptorantagonister indeholdende samme
JP3453188B2 (ja) 1994-05-23 2003-10-06 塩野義製薬株式会社 オレアノール酸誘導体の製造方法
ATE245447T1 (de) * 1995-06-02 2003-08-15 Shionogi & Co Inhibitor von gehirnödemen
JP3177826B2 (ja) 1995-08-29 2001-06-18 武田薬品工業株式会社 注射用粉末製剤
IT1282943B1 (it) 1995-12-27 1998-04-02 Sanofi Winthrop S P A Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico
JPH11209277A (ja) 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd 医薬組成物
EP0852951A1 (de) * 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
ES2253877T3 (es) 1998-03-03 2006-06-01 SHIONOGI & CO., LTD. Composiciones farmaceuticas que contienen el inhibidor de fosfolipasa((3-(2-amino-1,2-dioxoetil)-2-etil-1-(fenilmetil)-1h-indol-4-il)oxi)acetato de sodio.
ATE416790T1 (de) 1998-06-26 2008-12-15 Otsuka Pharma Co Ltd Wasserlösliche trockene zusammensetzungen
ES2233070T3 (es) 1998-08-20 2005-06-01 ELI LILLY & COMPANY Sintesis de analogos peptidicos ciclicos modificados en el anillo.
JP2000169372A (ja) 1998-09-29 2000-06-20 Takeda Chem Ind Ltd 抗真菌薬組成物
WO2000061109A1 (fr) 1999-04-12 2000-10-19 Shionogi & Co., Ltd. Procede de production de composition medicamenteuse renfermant un compose medicamenteux hydrophobe basique
DE60015672T2 (de) 1999-08-27 2005-12-01 Rohm And Haas Co. Verfahren zum Abstrippen von Polymerdispersionen oder Polymerlösungen
US6355611B1 (en) 1999-10-27 2002-03-12 Merck & Co., Inc. Salt form of a conjugate useful in the treatment of prostate cancer
US7973064B2 (en) * 2001-11-27 2011-07-05 The Board Of Trustees Of The University Of Illinois Method and composition for potentiating an opiate analgesic

Also Published As

Publication number Publication date
EP1407775A1 (en) 2004-04-14
KR100896375B1 (ko) 2009-05-08
JP4636795B2 (ja) 2011-02-23
JPWO2003007967A1 (ja) 2004-11-04
CN1286462C (zh) 2006-11-29
KR20040018470A (ko) 2004-03-03
CA2453996C (en) 2011-01-11
EP1407775A4 (en) 2007-01-10
US7645793B2 (en) 2010-01-12
US20040162344A1 (en) 2004-08-19
TWI232102B (en) 2005-05-11
CA2453996A1 (en) 2003-01-30
WO2003007967A1 (fr) 2003-01-30
BR0211269A (pt) 2004-08-03
CN1555265A (zh) 2004-12-15

Similar Documents

Publication Publication Date Title
AU2001279908A1 (en) Flexible linking piece for stabilising the spine
AU2002314168A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced mop-b expression
WO2004013001A3 (en) No-spill drinking products
DE602005020666D1 (en) Mif-hemmer
HK1042087A1 (en) Hydrochloride of fused-heterocycle compound.
MY133969A (en) Indoloquinazolinones
CA98622S (en) Container
USD497742S1 (en) Desk
HRP20050611A2 (en) Combination medicament
WO2004031352A3 (en) Interferon variants with improved properties
EP1267136A3 (en) Door gasket at a refrigerator or freezer
USD533786S1 (en) Container
HRP20041033A2 (en) Use of polymers comprising thermoplastic polymers as filtration aids and/or stabilising agent
AU2001260077A1 (en) Microfiltration using activated carbon
MXPA04000450A (es) Preparacion medica para inyeccion parenteral.
ZA200500219B (en) Modified bryodin 1 with reduced immunogenicity.
AU2003280581A1 (en) Fluororesin composition, molded fluororesin articles, fluororesin laminates and use of the laminates
AU144678S (en) Bottle
USD509393S1 (en) Shelf
MXPA03007625A (es) Trombopoyetina modificada con inmunogenicidad reducida.
AU2003260480A1 (en) Lock, particularly furniture lock
WO2006134457A8 (en) 2,5-bis-diamimne [1 , 4] benzoquinone-derivatives
MXPA03008402A (es) Insulina modificada con inmunogenicidad reducida.
EP1413233A3 (de) Wäschebügel, insbesondere für String-Tanga
PT1828139E (pt) Processo para a preparação de 10,11-dihidro-10-hidroxi-5hdibenzo[ b,f]azepin-5-carboxiamida

Legal Events

Date Code Title Description
FG Grant or registration